头颈癌患者的医师协助自杀:俄勒冈州回顾性队列分析
该回顾性队列研究利用俄勒冈州《尊严死亡法》数据,分析1998至2018年间57例接受医师协助自杀处方的头颈癌患者。39例(68.4%)服药死亡,最常见原发部位为口腔(33.3%)和口咽(30.8%),最常见终末担忧为丧失参与愉悦活动能力(79.5%)和丧失自主权(74.4%);服药死亡者教育程度较低(P = .015)。
要点
- 头颈癌患者PAS最常见原发部位为口腔和口咽。
- 主要终末担忧为丧失愉悦活动能力和自主权。
- 服药死亡者与未服药者在年龄、种族、婚姻、临终关怀入组率上无差异,但教育程度较低。
核心结论
- 头颈癌患者寻求PAS的主要原因为丧失参与愉悦活动的能力和丧失自主权。
- 服药死亡者教育程度低于未服药者(P = .015),其余人口学及临终关怀入组率无差异。
研究设计与样本
- 回顾性观察性队列研究,使用俄勒冈州《尊严死亡法》数据。
- 1998至2018年间共57例头颈癌患者接受DWDA处方。
主要发现
- 57例中39例(68.4%)服药死亡。
- 最常见原发部位为口腔(33.3%)和口咽(30.8%)。
- 最常见终末担忧为丧失参与愉悦活动的能力(79.5%)和丧失自主权(74.4%)。
- 药物给药无相关并发症。
- 服药死亡者与未服药者在年龄、种族、婚姻状况或临终关怀入组率上无差异。
关键数值与推荐
- 服药死亡者教育程度较低(P = .015)。
临床怎么用
- 耳鼻咽喉科医生应关注头颈癌患者对丧失功能和自主权的担忧,及时评估并干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A retrospective observational cohort study was conducted using data from Oregon's Death with Dignity Act (DWDA) to characterize patients with head and neck cancer (HNC) who seek physician-assisted suicide (PAS). Between 1998 and 2018, a total of 57 patients with HNC received DWDA prescriptions, of whom 39 (68.4%) died by administration of the prescribed medication. There were no associated complications with medication administration. The most commonly involved subsites were oral cavity (33.3%) and oropharynx (30.8%), and the most commonly cited end-of-life concerns were loss of ability to engage in activities that make life enjoyable (79.5%) and loss of autonomy (74.4%). There were no differences in age, race, marital status, or hospice enrollment rates between patients with HNC who died by administration and those who were prescribed but did not administer the medication. Patients who died by administration were generally less educated as compared to those who were prescribed but did not administer the medication (P = .015).
引用
- Kligerman MP, Divi V. Physician-Assisted Suicide for Patients with Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020. PMID: 32427518. doi:10.1177/0194599820923610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。